← The Record
Tuesday, September 22, 2026First edition · The read holds, with reservations. Confidence 82/100.
What changed
Baseline was 95-60, plus-83 and six clear after the 5-1 win over Boston on Sep 20. The 2-0 loss to New York on Sep 22 moved Tampa Bay to 95-61, plus-81 and five clear, with DRaysBay reporting both clubs have secured postseason spots. New items are MLB Trade Rumors on the 30th start for Martinez and single-source community chatter on Pete Fairbanks surgery talk, color around an unchanged race.
Why it matters
95-61 and five clear in the AL after a 2-0 blanking in the Bronx, Tampa Bay still owns first place and now feels the breath. Third baseman Junior Caminero powers a grinder that pitches tight and steals margin.
What to watch
Watch Baker workload through the Bronx nightcap and final two dates, whether Rasmussen and Martinez pitch on turn, and whether Caminero punishes Yankees pitching before Philadelphia.
What would change our mind
A lead of two games or fewer entering Philadelphia, a setback for Rasmussen, Martinez or Caminero, or a Bronx bullpen ERA above 4.00 would flip Tampa Bay from frontrunner to fragile.
The counterevidence
- Plus-81 trails New York at plus-139 and sits even with Boston at plus-80. The standings say frontrunner, the margin says vulnerable.
- Pitchers Freddy Peralta and Steven Matz carry 4.56 and 5.49 ERAs with 1.33 and 1.23 WHIPs. October lineups will hunt those turns.
- Center fielder Cedric Mullins hits .201 with a .621 OPS and shortstop Jorge Mateo hits .205. Those are two outs opponents can plan around.
For informational and editorial purposes only. This page does not accept, facilitate, or direct wagers. No sportsbook endorsement or recommendation is being made. Odds and lines may change and may be unavailable in your jurisdiction. Do not wager unless permitted by applicable law and only through an authorized operator. You must be 21 or older to wager in Florida. Gambling involves financial risk. If you or someone you know has a gambling problem, call
1-800-GAMBLER.